Dr. Andreas Anderluh

Angestellt, Projektmanager/Analytical Specialist - Corporate Method Validation, Octapharma Pharmazeutika Produktionsges.m.b.H.

Wien, Österreich

Fähigkeiten und Kenntnisse

Molekularbiologische Techniken
Projektmanagement
Datenanalyse
Mikrobiologie
Biowissenschaften
Methodenvalidierung
Drug Development
Patentmanagement
Biophysik
Zellkulturtechnik
Proteinreinigung
Klonierung
Fluoreszenzmikroskopie
Hochauflösende Mikroskopie
Technology transfer

Werdegang

Berufserfahrung von Andreas Anderluh

  • Bis heute 4 Jahre und 9 Monate, seit Okt. 2019

    Projektmanager/Analytical Specialist - Corporate Method Validation

    Octapharma Pharmazeutika Produktionsges.m.b.H.

    - Project management for developing new plasma-derived products - Preparation of documents for e.g. IND/IMPD submissions - Development and validation of analytical test methods for pharmaceutical products according to cGMP-guidelines and Pharmacopoeias, e.g. ICH, USP, Ph. Eur., WHO - Issuing of e.g. Master SOPs, method development plans/reports, validation plans/reports and risk assessments

  • Bis heute 5 Jahre und 9 Monate, seit Okt. 2018

    Corporate QC Analytical Method Validation - corporate Trainee

    Octapharma Pharmazeutika Produktionsges.m.b.H.

    Development and validation of analytical test methods according to cGMP-guidelines Project management for developing new products with cross-functional international teams Planning and coordination of experiments at various company sites in Europe Issuing of relevant documents, e.g. Master SOPs, method development plans/reports, validation plans/reports and risk assessments Issuing working instructions for QC laboratories Statistical evaluation of analytical results

  • 1 Jahr, Okt. 2017 - Sep. 2018

    Technology Transfer Officer, Life Science

    Institute of Science and Technology Austria
  • 1 Jahr und 1 Monat, Sep. 2016 - Sep. 2017

    Projektleiter Entwicklung, Molekularbiologie

    Institute of Science and Technology Austria

    Project leader for the development and commercialization of novel drug screening platforms and their application for in-house drug development; Project management; Qualification, development and validation of cell-based drug screening assays; Leading a small research team; design, coordination and execution of validation experiments in the lab; Assessment of potential cancer drug targets (GPCRs, RTKs); Establishment and maintenance of close contact to customers and partners; Business development:

  • 11 Monate, Okt. 2015 - Aug. 2016

    Postdoctoral Researcher

    Technische Universität Wien

    Molecular Biology/Biophysics/Biochemistry Evaluating the biochemical principles of serotonin transporter (SERT) aggregation in the plasma membrane in cell lines and primary neurons. - Building and validation of optical systems for protein characterization - Live-cell fluorescence superresolution microscopy - Molecular cloning - Preparation of primary neuronal cells - Cell culture, transient and stable transfections

Ausbildung von Andreas Anderluh

  • 3 Jahre und 5 Monate, Mai 2012 - Sep. 2015

    Biochemie und Molekularbiologie

    Technische Universität Wien

    Abschluss mit Auszeichnung; Evaluating the configuration of serotonin transporter complexes in the plasma membrane of living cells using single molecule microscopy techniques; unraveling the biochemical properties and kinetics of the complexes under physiological and pathophysiological conditions.

  • 8 Jahre, Okt. 2003 - Sep. 2011

    Microbiology/ Mikrobiologie

    Universität Wien

    Mikrobiologie/Genetik; Abschluss mit Auszeichnung

Sprachen

  • Deutsch

    Muttersprache

  • Englisch

    Fließend

  • Spanisch

    Grundlagen

21 Mio. XING Mitglieder, von A bis Z